Pharmaceutical innovation, competition and patent law : a trilateral perspective / edited by Josef Drexl, Nari Lee.

Format:

Book

Contributor:

Drexl, Josef.

Lee, Nari.

Language:

English

Subjects (All):

Biotechnology--Patents.

Biotechnology.

Patent laws and legislation.

Physical Description:

1 online resource (346 p.)

Place of Publication:

Cheltenham, UK ; Northampton, MA : Edward Elgar Pub., 2013.

Language Note:

English

Summary:

Public health, safety, and access to reasonably priced medicine are common policy goals of pharmaceutical regulations. As both the context for innovation and competitive structure change, industry actors dynamically challenge the balance between the incentive for protection and the achievement of those policy goals. Considering the arguments from the perspectives of innovation, competition law and patent law, this book explores the difficult question of balancing protection with access, highlighting the difficulties in harmonization and coordination. The contributors to this book including aca

Contents:

Cover; Copyright; Contents; Contributors; Acknowledgments; Introduction; PART I Patent protection for pharmaceutical methods; 1. The patentability of genetic diagnostics in US law and policy; 2. Patentability of pharmaceutical innovations: the European perspective; 3. Patentability of medical methods in Japan; PART II Data exclusivity and patent term extension: convergence or divergence; 4. Patent term restoration and non-patent exclusivity in the US; 5. Clinical data, data exclusivity and private investment protection in Europe

6. Patent term extension in Japan: an academic and comparative perspective7. Recent UK case law on supplementary protection certificates; 8. Patent term extension in Japan: focusing on the Pacif Capsule decision; PART III Balancing incentives and competition in Europe; 9. Strategic patenting by the pharmaceutical industry: towards a concept of abusive practices of protection; 10. Anticompetitive marketing in the context of pharmaceutical switching in Europe; 11. AstraZeneca and the EU sector inquiry: when do patent filings violate competition law?; Index

Notes:

Description based upon print version of record.

Includes bibliographical references and index.

ISBN:

0-85793-246-2

OCLC:

854845917